Page 129 - 2026 SMOG
P. 129

FUROSEMIDE (LASIX)
                              Class/Mechanism of Action
         •  Antihypertensive; Loop Diuretic
           Inhibits reabsorption of sodium and chloride in the kidney, causing increased loss of water,
           sodium, chloride, magnesium, and calcium in the urine. When given IV, it also causes rapid
           venous dilation—symptomatic improvement of acute pulmonary edema approximately
           15–20min.
                                    Indications
         •  Labeled Indications
              ˚  Management of edema associated with heart failure, cirrhosis of the liver (i.e., ascites), or
             kidney disease (including nephrotic syndrome); acute pulmonary edema
                                  Contraindications
         •  Hypersensitivity to furosemide or any component of the formulation
         •  Anuria (no pre-hospital utility in hypovolemic shock)
                            Adverse Reactions/Precautions
         •  Can cause profound diuresis with resulting shock and electrolyte depletion. Monitor closely!
              ˚  May cause: Hypovolemia, hypotension, hyponatremia, hypokalemia
         •  May potentiate the effect of additional antihypertensives
         •  May lead to Acute Kidney Injury due to fluid loss
         •  Ototoxicity: associated with hearing loss and tinnitus; generally reversible
         •  Pregnancy: Category C
         •  Lactation: Use caution; large doses suppress volume and lactation
                                Dose/Administration
                                                    PEDIATRIC
                      ADULT
                                              (Always reference Broselow Tape)
         Acute Pulmonary Edema           Edema (Heart Failure)
         •  IV                           •  IV/IM
              ˚  40mg over 1–2min. If the response is not     ˚  Initial: 1mg/kg as a single dose
             adequate within 1hr, may increase the
                                             If necessary, increase dose by up to
             dose to 80mg                     ˚  1mg/kg and give greater than 2hr after
         Edema (Heart Failure)               the previous dose, repeating until desired
         •  IV/IM                            response is achieved, to a maximum dose
              ˚  Initial: 20–40mg once, then titrate prn   of 6mg/kg.
             to an effective dose. If the initial dose
             does not result in diuresis, double the
             individual dose (rather than administering
             the same dose more frequently) until
             diuresis occurs.
         •  Continuous IV Infusion
              ˚  Initial: 5mg/hr; if diuretic response is
             not adequate, repeat IV bolus dose and
             increase continuous infusion to 10mg/hr;
             continue to bolus and titrate infusion prn
             up to 40mg/hr

                          2026 Standard Medical Operating Guidelines (SMOG)  •   121
   124   125   126   127   128   129   130   131   132   133   134